Microfluidic Cartridge Integrating CMOS Biosensor

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods face challenges in integrating CMOS technology with fluidic channels in microfluidic cartridges, particularly in maintaining active area for reagent delivery and illumination, and sealing PCR regions due to microbubbles in PCR mix.

Innovation Solution

A microfluidic cartridge design featuring a stack of fluidics layers with a CMOS biosensor integrated, where the biosensor's active area is kept clear for reagent delivery and illumination, and membrane valves are used to reversibly seal the PCR region from the reagent mixing and distribution region, preventing microbubble expansion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If fluidic channels are designed within the CMOS surface, then integration of CMOS technology and fluidics is achieved, but active area is reduced and flow patterns become complicated

Engineering Contradiction:
Improveintegration of CMOS and fluidicsVSAvoidactive area
Core Design Contradiction:
Device complexityVSArea of moving object

Solution Approach 1:

The patent transitions from two-dimensional integration (channels on CMOS surface) to three-dimensional integration by stacking fluidic layers above and below the CMOS sensor. This vertical arrangement preserves the full active area of the CMOS sensor while achieving complete integration of fluidic functionality through multiple layers connected via through-silicon vias and side channels.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If microbubbles are present in the PCR mix, then PCR reaction can proceed, but microbubbles expand during PCR and interfere with sealing

Engineering Contradiction:
Improvesealing of PCR regionVSAvoidmicrobubble expansion
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent performs preliminary sealing of the PCR region using membrane valves before the PCR reaction begins. This pre-sealing action prevents microbubbles from expanding and compromising the seal during the heating process, as the membrane valves are already in place to contain the pressure changes that occur during thermal cycling.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs flexible membrane valves made of thin film materials that can dynamically respond to pressure changes during PCR. These membranes can flex to accommodate microbubble expansion while maintaining the seal, and can be actuated to open or close fluidic pathways as needed during the sequencing process.

Inventive Principle:
Principle #30Flexible shells and thin films

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This design ensures efficient nucleic acid sequencing by maintaining the biosensor's active area for reagent delivery and illumination while effectively sealing the PCR region, preventing microbubble interference and enhancing the reliability of PCR operations.

Implementation Method 1

membrane valves that are configured to reversibly stop the PCR region from fluidic communication with the reagent mixing and distribution region

Methodology Applied
Scientific EffectMembrane valve sealing:

Implementation Method 2

a solid state CMOS biosensor integrated in the stack. The biosensor has an active area configured to detect signals of biological reactions

Methodology Applied
Scientific EffectCMOS detection:

Data Source

PatentEP3698874B1Disposable, integrated microfluidic cartridge and methods of making the same
Publication Date: 2024.07.31 ILLUMINA INC
  • EP3698874B1 patent drawingFigure 1
  • EP3698874B1 patent drawingFigure 2
  • EP3698874B1 patent drawingFigure 3

AI summary

The disclosed embodiments concern microfluidic cartridges for detecting biological reactions. In some embodiments, the microfluidic cartridges are configured to perform sequencing operations on a nucleic acid sample. In one aspect, a microfluidic cartridge includes a stack of fluidics layers defining channels and valves for processing the nucleic acid sample to be sequenced, and a solid state CMOS biosensor integrated in the stack. The biosensor has an active area configured to detect signals of biological reactions, wherein substantially all of the active area is available for reagent delivery and illumination during operation. In another aspect, a microfluidic cartridge includes: (a) a flow cell including a reaction site area encompassing one or more reaction sites; (b) fluidics channels for delivering reactants to and/or removing reactants from the reaction site area; (c) a biosensor having an active area configured to detect signals of biological reactions in the reaction site area. The reaction site area is proximal to the active area of the biosensor and the reaction site area spans substantially all of the active area of the biosensor. In some embodiments, the fluidics channels do not substantially overlap with the active area of the biosensor. Methods for manufacturing and operating the microfluidic cartridges are also disclosed.